Blog
Complete Guide to Supplement Stacks
Unfair Team • February 5, 2026
A supplement stack is a planned protocol: specific ingredients, doses, timing, and stop criteria chosen to change specific outcomes in a specific person, with a feedback loop that decides what stays, what goes, and what changes.
Most “stacks” fail because they are treated like a shopping list instead of an experiment.
Table of contents
| Section | What you’ll get |
|---|---|
| What a supplement stack is | A definition that prevents 80% of mistakes |
| Why stacks fail | The failure modes that cause wasted money and avoidable risk |
| The stack-building process | A complete workflow you can follow in one sitting |
| Decision rubric | A way to choose candidates rationally, not by vibes |
| Stack template | Foundations vs modules, with evidence-strength labels |
| Dosing, timing, product selection | Practical dosing windows and quality checks |
| Running and iterating | Baseline periods, review cadence, washouts |
| Measurement | Simple metrics you can log consistently |
| Safety | Contraindications, interaction categories, stop rules |
| Minimum viable stack | Starting small without “doing nothing” |
| Examples | Complete protocols for common goals |
| Using Unfair | How to implement the loop in the app without losing context |
What a supplement stack is
A good stack has four properties.
It is goal-defined: you can name the outcome you want, the population you’re in, and how you’ll measure the outcome.
It is testable: you can plausibly detect the effect (or lack of effect) within a defined time window.
It is constrained: you can identify the likely risks and interactions up front, and you avoid unnecessary complexity.
It is revisable: it has a scheduled review, and decisions are based on logs, not memory.
If you want the beginner version of this workflow first, see Building Your First Supplement Stack.
Why stacks fail
Most failures are predictable. Fix these first and your odds of getting a real signal go up.
Failure mode: unclear objective. “More energy” can mean less sleep debt, better iron status, lower anxiety, higher carbohydrate intake, or just more caffeine. A supplement can’t be evaluated against a vague goal.
Failure mode: too many simultaneous changes. If you add six ingredients at once and you feel better (or worse), you learned nothing. N-of-1 trial methods exist because single-person experimentation can be done rigorously when changes are planned and measured.1
Failure mode: the outcome is not measurable. If your only metric is “how I feel this week,” noise wins. You need at least one stable subjective measure and one objective proxy you can collect repeatedly.
Failure mode: underdosing, overdosing, or mistiming. Many supplements have a narrow “effective dose range” and a specific time-to-effect. If you don’t know whether you should expect an acute effect (same day) or a slow effect (weeks), you’ll churn constantly.
Failure mode: hiding behind blends. Proprietary blends and “kitchen sink” pre-workouts often make it impossible to know what you took and at what dose. Some high-risk supplement categories have a long history of adulteration with unapproved drugs or drug analogs; when your stack depends on those categories, the risk profile changes dramatically.23
Failure mode: ignoring the real constraint: adherence. A theoretically perfect protocol that you follow 60% of the time loses to a good protocol you follow 95% of the time.
If you want a deeper classification of supplement types and risk tiers, see Understanding Supplement Categories.
The stack-building process
Use this as your default workflow. It’s conservative on purpose; you can speed it up later when you know how you respond.
| Phase | What you do | Default duration | What success looks like |
|---|---|---|---|
| Baseline | Keep routines stable; log outcomes and confounders (sleep, training, caffeine, alcohol) | 14 days | You have “normal variability” for your metrics |
| Build | Choose 1–2 foundation items + 1 goal module, using the rubric below | 30–60 minutes | You can explain why each ingredient is there |
| Ramp | Start at the low end; increase only if needed and tolerated | 3–7 days | No meaningful side effects; adherence >90% |
| Run | Hold everything steady; no “tinkering” | 14–42 days (depends on ingredient) | Enough time to detect the expected effect |
| Review | Compare to baseline; decide keep / adjust dose / adjust timing / remove | Every 2–4 weeks | Decisions based on logs and predefined criteria |
| Optional washout | Stop one ingredient at a time when attribution is unclear or side effects appear | 3–14+ days (depends) | You can attribute benefits/harms more confidently |
Decision rubric for picking candidates
This rubric forces you to answer the questions that matter: is there evidence for your outcome, is it safe for your situation, and can you actually test it?
Score each criterion from 0–2 (0 = no/poor, 1 = mixed/unclear, 2 = yes/strong). A “good bet” candidate usually scores 10+ and has no red-flag safety issues for you.
| Criterion | 0 | 1 | 2 | What you’re looking for |
|---|---|---|---|---|
| Outcome match | No direct link to your outcome | Indirect or mixed outcomes | Direct evidence for your outcome | Trials that measure what you care about |
| Evidence quality | Mostly anecdotes or animal data | Small RCTs; inconsistent | High-quality syntheses or large RCTs | Systematic reviews; meta-analyses; guidelines |
| Effect size (typical) | Tiny or unclear | Small but plausible | Meaningful and repeatable | Magnitude you can detect in your life |
| Time-to-effect | Unknown | Long/variable | Predictable | You know when to evaluate it |
| Safety for you | High-risk or contraindicated | Some cautions | Low-risk in your context | Your meds, conditions, labs, history |
| Interaction load | Many likely interactions | Some possible | Few likely | Especially stimulant and anticoagulant categories |
| Practicality | Hard to source or take | Mild hassle | Easy | Simple schedule, tolerable form |
| Testability | Too many confounders | Some confounders | Clean test | You can hold other variables steady |
| Cost-effectiveness | Poor ROI | Acceptable | High ROI | You’d pay for this signal |
Stack template: foundation vs modules
A useful mental model is “stability first, then specificity.”
Foundations are about raising the floor: correcting likely gaps, reducing variance, and supporting the basics that make everything else work. Modules target a specific outcome with a defined evaluation window.
If you want a deeper “foundation-first” approach, see Supplement Foundations for Sustainable Results.
| Layer | What it’s for | Typical candidates (examples, not requirements) | Evidence strength | Why that label |
|---|---|---|---|---|
| Foundation: adequacy and gaps | Fixing intake problems that masquerade as “needs a stack” | Protein supplement to hit target intake; psyllium for soluble fiber; vitamin D only when deficient/high-risk; omega-3 when fish intake is low | Strong to Moderate | Protein and fiber have consistent effects when intake is low; vitamin D benefits are concentrated in deficiency; omega-3 effects depend heavily on dose and endpoint4567 |
| Foundation: performance basics | High-signal ergogenic support that’s easy to test | Creatine monohydrate; caffeine (strategic) | Strong | Repeated findings across many RCTs and syntheses for performance outcomes; predictable dosing and timing8910 |
| Module: sleep and circadian | Sleep onset, timing, and next-day functioning | Melatonin (timed for sleep onset/circadian shift); magnesium (if low intake/constipation); glycine (small trials) | Moderate to Limited | Melatonin shows modest but consistent changes in sleep-onset metrics; magnesium and glycine evidence is narrower and more heterogeneous111213 |
| Module: focus and mental energy | Acute attention/alertness with less jitter | Caffeine + L-theanine | Moderate | Task-specific benefits with mixed study designs; more consistent for attention-switching and reaction-time tasks than for broad “productivity”1415 |
| Module: stress resilience | Subjective stress/anxiety measures (not “life transformation”) | Ashwagandha extracts (standardized) | Limited to Moderate | Meta-analyses suggest improvements in stress/anxiety and cortisol, but many trials are small; product heterogeneity matters1617 |
| Module: endurance and high-intensity work | Time-to-exhaustion, time-trial, repeated bouts | Dietary nitrate (beetroot); beta-alanine | Moderate | Effects are usually small and context-dependent; strongest for specific durations/intensities; require correct dosing/time frame1819 |
| Module: joints/tendons | Pain/function with training, connective tissue support | Collagen peptides (often paired with training) | Limited | Some trials show modest pain/function changes; evidence varies by population and outcome20 |
A practical rule: never add a module until your foundation is stable enough that you can notice a change.
Dosing, timing, and product selection
“Correct” dosing is less about the perfect milligram and more about matching the dosing strategy to the expected biology, then making adherence automatic.
Dosing strategy: acute vs chronic
Acute supplements are evaluated on the same day or within a few days because the effect is immediate and reversible. Caffeine is the obvious example; performance effects are commonly seen with moderate doses (often 3–6 mg/kg) taken pre-exercise, with typical improvements in endurance metrics on the order of a few percent in meta-analytic summaries.10
Chronic supplements need saturation or remodeling. Creatine typically needs weeks for full effect in many contexts; protein and fiber change outcomes on the scale of weeks; omega-3 changes tissue levels over longer horizons and is easiest to evaluate against lipids or inflammation proxies you can actually measure.48
Make timing boring
Your schedule should minimize decision points. “Boring” stacks get followed.
| Timing window | What usually fits here | What to avoid here | Why |
|---|---|---|---|
| Morning | Foundation items that don’t affect sleep; fiber with water; omega-3 with food | New stimulants if you’re also testing sleep | Morning is a consistent anchor; reduces missed doses |
| Pre-training (30–180 min) | Caffeine; nitrates (often earlier); creatine is not time-critical | Multiple overlapping stimulants | Pre-workout is where stacks accidentally become stimulant cocktails |
| Evening | Sleep module trials (melatonin timed; glycine; magnesium if tolerated) | Anything that can increase arousal | Keeps sleep experiments clean |
| With meals | Fat-soluble vitamins; omega-3; magnesium (if GI tolerance) | Fiber too close to meds | Food can improve tolerability; fiber can reduce absorption of some meds |
Product quality is part of dose
Supplements are not approved by the FDA for safety or effectiveness before they are sold; manufacturers are responsible for ensuring products meet legal standards, and enforcement is largely post-market.21 That matters more when you stack multiple products.
Practical quality checks that change your risk, not just your feelings:
Third-party verification for identity/purity and label accuracy. Programs such as USP’s Dietary Supplement Verification Program and NSF Certified for Sport exist because label accuracy and contamination are real failure modes.2223
If you are drug-tested or compete, treat supplements as a doping risk category. Even well-meaning products can be contaminated; certification reduces risk, it does not eliminate it.2423
Avoid proprietary blends for anything you want to test. If the label won’t tell you the dose, you can’t run a protocol.
Avoid “grey-zone stimulant” products. The FDA has warned about DMAA (1,3-dimethylamylamine) being marketed in supplements and about health risks, especially when combined with other stimulants like caffeine.25
Run it like an experiment: baseline, ramp, review, washout
If you want “results without hype,” you need a loop that protects you from motivated reasoning.
Baseline: establish your noise floor
A baseline is not a formality. It tells you what “normal variability” looks like so you don’t mistake regression-to-the-mean for a supplement effect.
Baseline log minimum: your target metrics (subjective + objective), sleep, training, caffeine, alcohol, and anything that predictably changes your outcome (travel, illness).
Ramp: start low, then earn dose increases
The goal of a ramp is not to “feel it.” It’s to find the lowest dose that produces a measurable benefit without side effects.
Many side effects are dose-dependent and non-informative (they tell you you took something, not that it worked). Beta-alanine tingles are the classic example; splitting doses and using sustained-release forms can reduce paresthesia while maintaining the intended chronic effect.19
Review cadence: pick a calendar day
Memory is the enemy. Pick a review cadence that matches time-to-effect.
Acute modules (caffeine/theanine, nitrates): you can review weekly because you get repeated trials.
Chronic modules (creatine, beta-alanine, fiber): review every 3–6 weeks, because effect sizes emerge slowly and noise is high week-to-week.
Washout: use it when attribution matters
Washouts are not required for every decision. Use them when:
You have side effects and need to identify the cause.
You have a benefit but can’t tell which ingredient produced it.
You’re simplifying the stack (often the best “upgrade”).
Default washout guidance is about biology, not ideology. Some effects reverse quickly; others are slow to clear.
| Ingredient type | Examples | When you can expect effects | When you can expect reversal after stopping (typical) | Why |
|---|---|---|---|---|
| Acute stimulant | Caffeine | Same day | Days (withdrawal possible) | Fast pharmacology; tolerance/withdrawal complicate interpretation1026 |
| Acute nitric oxide support | Nitrates (beetroot) | Same day (with correct timing) | Days | Effect is tied to intake and oral microbiome; timing matters18 |
| Tissue saturation | Creatine | Weeks | Weeks | Muscle creatine stores change gradually; evaluate on longer windows8 |
| Buffering adaptation | Beta-alanine | Weeks | Weeks | Carnosine increases over time and decays over time19 |
| Circadian signal | Melatonin | Same day to weeks (timing-dependent) | Days | Timing drives circadian effect; keep schedule stable1127 |
| Fiber/metabolic | Psyllium | Days to weeks | Days to weeks | Changes stool/LDL metrics over time; adherence is the limiter6 |
Measurement that you’ll actually do
A stack is only as good as its measurement. Your goal is not perfect data; your goal is data that changes decisions.
Separate outcomes into three buckets
Primary outcome: the reason you’re doing this. One metric.
Secondary outcomes: what you hope changes but can’t make the whole project about. Two to four metrics.
Safety/tolerability: what would make you stop. Always tracked.
Use both subjective and objective proxies
Subjective measures are legitimate, but they need structure. A daily 1–10 rating with an anchor description is far better than “felt good.”
Objective proxies keep you honest, but only if you’ll collect them.
Examples that people actually sustain:
Sleep: sleep onset latency (minutes); total sleep time; subjective sleep quality (1–10); morning sleepiness (1–10); wearable-derived sleep timing if you have it.
Focus: timed deep-work blocks completed; distraction count (simple tally); reaction-time test if you’ll repeat it.
Training: session RPE; total volume for key lifts; time-trial completion time; repeated sprint output.
Metabolic: fasting weight trend (weekly average); waist circumference (weekly); lipids/glucose only if you will test in a consistent way (ideally through a clinician).
Iteration log template
Use this table as your weekly review record. The point is to preserve context so you stop re-running the same experiment forever.
| Week | Stack version | Change made | Adherence (%) | Primary outcome (avg) | Secondary outcomes | Side effects / safety notes | Confounders (travel, illness, alcohol, training changes) | Decision |
|---|---|---|---|---|---|---|---|---|
| 0 (baseline) | None | None | - | Start trial | ||||
| 1 | ||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 |
Safety: interactions, contraindications, stop criteria
A “safe stack mindset” is not fear. It’s operational clarity: you know what would make you stop and when you should involve a clinician.
High-yield interaction categories
This table is not exhaustive. It is the set of interaction categories that commonly matter in real life stacks.
| Category | Why it matters | Common stack ingredients that trigger caution | Typical mitigation |
|---|---|---|---|
| Stimulants and sympathomimetics | Additive heart rate, blood pressure, anxiety, sleep disruption | Caffeine; stimulant pre-workouts; DMAA-like products | Keep stimulant count low; dose earlier; avoid grey-zone stimulants1025 |
| Anticoagulants/antiplatelets | Bleeding risk and procedural risk; monitoring changes | High-dose omega-3; some herbal products | Clinician review if you’re on anticoagulants; avoid “random herbs” stacking428 |
| Sedatives and CNS depressants | Additive sedation, impaired driving, next-day grogginess | Melatonin; high-dose magnesium; combined “sleep blends” | Start low; single ingredient trials; stop if next-day impairment1112 |
| Thyroid and endocrine-sensitive contexts | Some botanicals may affect thyroid hormones or symptoms | Ashwagandha (case reports and mechanistic concerns) | Avoid if thyroid disease unless supervised; stop if symptoms shift1629 |
| Antibiotics/bisphosphonates absorption | Minerals can reduce absorption of some meds | Magnesium; iron; calcium | Separate dosing by hours; follow clinician/pharmacist advice12 |
| Lab test interference | Supplements can distort labs and clinical decisions | Biotin (common in “hair/skin/nails” products) | Tell clinician; pause biotin before relevant tests per guidance30 |
Stop criteria (use these)
Stop criteria are not moral judgments; they are pre-commitments that prevent escalation.
Stop immediately and reassess if you get: chest pain; fainting; severe palpitations; severe shortness of breath; signs of allergic reaction; severe mood changes; jaundice or dark urine after starting a botanical.
Stop and simplify (remove the most recent change first) if you see: persistent insomnia; anxiety increase; GI distress that disrupts life; headaches that correlate with dosing; a sustained adverse change in your primary metric.
If you are taking prescription medications, are pregnant/breastfeeding, have kidney or liver disease, have a history of bipolar disorder/psychosis, have arrhythmias, or you’re managing a chronic condition, involve a clinician before running multi-ingredient stacks. The cost is usually one visit; the benefit is avoiding the “stack as uncontrolled polypharmacy” problem.
A note on “safe” categories
Some supplement categories are structurally higher risk because of adulteration incentives and historical patterns: sexual enhancement, rapid weight loss, and some bodybuilding/pre-workout products. The FDA has repeatedly issued warnings and recalls for products tainted with unapproved drugs (for example, PDE-5 inhibitor ingredients in “male enhancement” products).331 If your stack depends on these categories, your safety model should change.
Minimum viable stack: earn complexity
The minimum viable stack is the smallest set of changes that can plausibly move your outcomes while keeping attribution and safety manageable.
A good minimum viable stack usually looks like one foundation plus one module, not five “essentials.”
Minimum viable stack options
| Goal | Minimum viable stack | Evidence strength | What makes it “minimum viable” |
|---|---|---|---|
| General training support | Creatine monohydrate daily; optional caffeine only on key sessions | Strong | Two ingredients with predictable effects and easy measurement810 |
| Sleep onset and schedule | Timed melatonin (lowest effective dose) | Moderate | Single ingredient with measurable outcomes and clear stop rules1127 |
| Cholesterol support (non-drug adjunct) | Psyllium daily with water | Moderate to Strong | Dose-dependent LDL reduction; easy adherence and measurement if you have labs632 |
| Stress resilience | Standardized ashwagandha extract trial | Limited to Moderate | A single botanical with measurable subjective outcomes; requires stricter stop rules1629 |
Example stacks: complete protocols
These examples are meant to be realistic and conservative. They are not maximal. They are designed to teach the process: who fits, who should avoid, what to track, and how to iterate.
Example: Focus and deep work with fewer jitters
Evidence strength Moderate. Caffeine reliably improves alertness and performance; combining with L-theanine appears to improve attention-switching and reduce distraction in some tasks, with effects that are task-specific and not universal.101415
Fits People who want acute focus for cognitively demanding work; people who tolerate caffeine but dislike jitters.
Avoid if Pregnancy; uncontrolled hypertension; arrhythmias; panic disorder that flares with stimulants; insomnia that is not already controlled.
Protocol (starting ranges)
| Ingredient | Conservative starting range | Timing window | Notes |
|---|---|---|---|
| Caffeine | 50–100 mg (or ~1 mg/kg) | 30–60 min before work block | Increase only if needed; avoid late-day dosing1026 |
| L-theanine | 100–200 mg | With caffeine | Often tested at ~100 mg theanine with ~50 mg caffeine in trials14 |
What to track Number of uninterrupted work blocks completed; distraction count; subjective focus (1–10); sleep onset latency that night.
First change if it fails Reduce caffeine dose and move it earlier; if still jittery, keep caffeine fixed and test higher theanine within conservative bounds; if focus is unchanged, stop and reassess whether sleep debt, nutrition, or workload design is the real constraint.
Stop criteria Persistent anxiety, tremor, palpitations, or sleep disruption lasting more than three days at the same dose.
Example: Strength and hypertrophy support (non-stimulant core)
Evidence strength Strong for creatine; Strong to Moderate for protein supplementation when it helps you hit total protein targets.894
Fits People doing progressive resistance training; people who are inconsistent on protein intake; older adults looking for a low-risk performance foundation.
Avoid if Known kidney disease without clinician guidance; anyone who cannot tolerate water-weight changes (for example, weight-class sport close to competition).
Protocol (starting ranges)
| Ingredient | Conservative starting range | Timing window | Notes |
|---|---|---|---|
| Creatine monohydrate | 3 g/day | Any time daily | Timing is not critical; consistency is89 |
| Protein supplement (if needed) | 20–40 g per serving | As needed to reach daily target | Total protein intake and distribution matter more than a specific product45 |
What to track Training volume and/or estimated 1RM trends; body weight (weekly average); GI tolerance; subjective recovery.
First change if it fails If strength is not moving, the first “stack change” is usually not a supplement; it’s training progression or total calories. If training is progressing but recovery is poor, verify sleep and total protein intake before adding more ingredients.
Stop criteria New GI distress that disrupts training; new swelling/edema not explained by creatine water weight; any lab abnormalities discussed with a clinician (note that creatine can raise serum creatinine without harming GFR in many contexts, which can confuse interpretation).33
Example: Sleep onset and circadian alignment
Evidence strength Moderate for melatonin on sleep onset latency and circadian timing; Limited for add-ons like glycine unless you respond clearly.111327
Fits Difficulty falling asleep at a consistent time; jet lag or shifted schedules; people who want to reduce sleep-onset latency without heavy sedatives.
Avoid if Pregnancy/breastfeeding; epilepsy meds or anticoagulants without clinician guidance; autoimmune disease flares you’re monitoring closely; anyone with a history of worsening mood symptoms with sleep agents.
Protocol (starting ranges)
| Ingredient | Conservative starting range | Timing window | Notes |
|---|---|---|---|
| Melatonin | 0.3–1 mg | 1–3 hours before target bedtime | Timing matters; higher doses are not always better1127 |
| Optional glycine (trial) | 3 g | 30–60 min before bed | Small trials suggest subjective sleep improvements; treat as experimental add-on13 |
What to track Sleep onset latency; total sleep time; next-day sleepiness; vivid dreams/nightmares; morning grogginess.
First change if it fails Adjust timing before changing dose. For many people, timing is the whole intervention. If timing changes do nothing, stop and shift attention to light exposure, caffeine timing, and bedtime behavior; supplements are weak against strong circadian inputs.
Stop criteria Next-day impairment; mood changes; persistent abnormal dreams; any concerning symptoms. If you use melatonin, consider product quality: analyses have found large variability in labeled vs measured melatonin content and occasional serotonin contamination in commercial products, which makes third-party testing materially relevant.34
Example: Stress resilience (measurable, not magical)
Evidence strength Limited to Moderate. Meta-analyses suggest reductions in stress/anxiety measures and cortisol, but trials are often small and products vary; rare liver injury case reports exist, which changes stop criteria.161729
Fits People with elevated perceived stress who want a structured trial; people who can track anxiety/stress scores consistently.
Avoid if Liver disease; thyroid disease; autoimmune disease; pregnancy/breastfeeding; concurrent sedative use without clinician guidance.
Protocol (starting ranges)
| Ingredient | Conservative starting range | Timing window | Notes |
|---|---|---|---|
| Ashwagandha (standardized extract) | 250–600 mg/day (per product standardization) | With food; split dose if needed | Choose a standardized extract with clear dosing; avoid “mystery blends”1617 |
What to track Daily stress rating (1–10) with a written anchor; anxiety symptoms; sleep quality; GI symptoms; any signs of jaundice or dark urine.
First change if it fails If no change after 4–6 weeks with good adherence, stop. If partial benefit with sedation, reduce dose or move earlier in the day.
Stop criteria Any signs of liver injury (jaundice, dark urine, intense itching, right upper abdominal pain), severe GI symptoms, or worsening mood. Case reports describe cholestatic liver injury patterns after ashwagandha in some individuals; treat this as a real stop condition, not internet drama.29
Example: Endurance or hard intervals (small edges, correct timing)
Evidence strength Moderate. Dietary nitrate tends to help certain endurance or high-intensity efforts, especially in the ~2–10 minute range; beta-alanine has more consistent value for repeated high-intensity efforts over weeks, with small-to-moderate effects depending on protocol.1819
Fits People doing interval work or time-trials who can repeat similar sessions; athletes who want a measurable performance edge without stacking stimulants.
Avoid if Use of PDE-5 inhibitors or nitrate medications; low blood pressure; significant GI sensitivity.
Protocol (starting ranges)
| Ingredient | Conservative starting range | Timing window | Notes |
|---|---|---|---|
| Dietary nitrate (beetroot) | Product-specific dose; aim for studied nitrate range (often ~5–9.9 mmol/day in multi-day protocols) | Often ~2–3 hours pre-session | Avoid antiseptic mouthwash around dosing; oral bacteria matter18 |
| Beta-alanine | 3.2–6.4 g/day (split doses) | Daily for 4+ weeks | Split dosing reduces tingles; expect slow onset19 |
What to track Performance on a repeatable session (time-trial time, average power, interval completion); GI tolerance; perceived exertion; sleep if dosing includes stimulants (it doesn’t need to).
First change if it fails Fix timing for nitrate before changing dose; if nitrate is inconsistent, drop it and keep beta-alanine for a longer run; if beta-alanine side effects are bothersome, lower dose and split further.
Stop criteria Hypotension symptoms, severe headaches, severe GI symptoms.
Running the loop in Unfair
The hard part of stacking is not knowledge; it’s execution and recall.
A practical way to implement this workflow in Unfair:
Convert a recommendation bundle into an active stack so the “protocol version” is explicit.
Schedule doses as events tied to your real anchors (wake time, first meal, training window, bedtime) so adherence is automatic.
Log each dose event and add a short note only when something changes (symptom shift, side effect, travel, poor sleep). This keeps the data sparse but decision-relevant.
Run a weekly review note that mirrors the iteration log table: adherence, primary outcome trend, confounders, and the decision. When you revise the stack, you preserve the full history instead of restarting from scratch.
This loop stays useful even if you never touch wearables or lab tests, because it forces consistent inputs and honest review.
References
This article is for education and should be used with clinician guidance when you have medical conditions, take prescription medications, or are pregnant/breastfeeding.
Vohra S, Shamseer L, Sampson M, et al. (CENT Group). CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. 2015. BMJ. https://www.bmj.com/content/350/bmj.h1738
↩Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. 2018. JAMA Network Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC6324457/
↩U.S. Food and Drug Administration. One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil. 2025. FDA Safety Alerts/Recalls. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/one-source-nutrition-inc-issues-voluntary-nationwide-recall-vitality-capsules-due-presence
↩Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. 2018. Br J Sports Med. https://pubmed.ncbi.nlm.nih.gov/28698222/
↩Jäger R, Kerksick CM, Campbell BI, et al. International Society of Sports Nutrition Position Stand: protein and exercise. 2017. J Int Soc Sports Nutr. https://www.tandfonline.com/doi/full/10.1186/s12970-017-0177-8
↩Gholami Z, et al. Psyllium supplementation and lipid profiles: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12690803/
↩Bouillon R, et al. Health effects of vitamin D supplementation: evidence from randomized controlled trials and Mendelian randomization studies. 2023. (Review; full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10592274/
↩Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. 2017. J Int Soc Sports Nutr. https://www.tandfonline.com/doi/full/10.1186/s12970-017-0173-z
↩Zhang H, et al. Effects of creatine supplementation on muscle strength gains: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12665265/
↩Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. 2021. J Int Soc Sports Nutr. https://pmc.ncbi.nlm.nih.gov/articles/PMC7777221/
↩Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: Melatonin for the treatment of primary sleep disorders. 2013. PLoS One. https://pmc.ncbi.nlm.nih.gov/articles/PMC3656905/
↩National Institutes of Health, Office of Dietary Supplements. Magnesium: Health Professional Fact Sheet. Updated 2026. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
↩Soh J, et al. The effect of glycine administration on the characteristics of sleep and its mechanism: a review. 2023. (Review; full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10828290/
↩Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. 2008. Nutritional Neuroscience. https://pubmed.ncbi.nlm.nih.gov/18681988/
↩Payne ER, et al. Effects of Tea (Camellia sinensis) or its Bioactive Compounds on Cognitive Performance: A Systematic Review and Meta-analysis. 2025. Nutrition Reviews. https://academic.oup.com/nutritionreviews/article/83/10/1873/8123998
↩National Institutes of Health, Office of Dietary Supplements. Ashwagandha: Health Professional Fact Sheet. 2025. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
↩Akhgarjand C, et al. Does Ashwagandha supplementation have a beneficial effect on stress and anxiety? Systematic review and dose-response meta-analysis of randomized controlled trials. 2022. (PubMed record). https://pubmed.ncbi.nlm.nih.gov/36017529/
↩Silva KVC, et al. Factors that Moderate the Effect of Nitrate Ingestion on Exercise Performance: Systematic Review and Meta-analysis. 2022. The American Journal of Clinical Nutrition. https://www.sciencedirect.com/science/article/pii/S2161831323000455
↩Saunders B, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. 2017. Br J Sports Med. https://pubmed.ncbi.nlm.nih.gov/27797728/
↩Khatri M, et al. The effects of collagen peptide supplementation on body composition, muscle soreness, and damage following exercise: a systematic review. 2021. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8521576/
↩U.S. Food and Drug Administration. FDA 101: Dietary Supplements. 2022. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements
↩U.S. Pharmacopeia (USP). Dietary Supplement Verification Program. https://www.usp.org/verification-services/dietary-supplements-verification-program
↩NSF. Certified for Sport® Program. https://www.nsf.org/consumer-resources/articles/certified-for-sport-program
↩International Testing Agency (ITA). Supplements. https://ita.sport/athlete-hub/supplements/
↩U.S. Food and Drug Administration. DMAA in Products Marketed as Dietary Supplements. 2023. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements
↩U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much? 2024. https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much
↩Auger RR, Burgess HJ, Emens JS, et al. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: an update for 2015. 2015. J Clin Sleep Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC4582061/
↩National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
↩Lubarska M, et al. A Case Report of Ashwagandha-Induced Liver Injury. 2023. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10002162/
↩U.S. Food and Drug Administration. Biotin Interference with Troponin Lab Tests (Assays Subject to Biotin Interference). 2022. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference
↩Tucker J, Fischer T. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. 2018. JAMA Network Open. https://pmc.ncbi.nlm.nih.gov/articles/PMC6324457/
↩Chen C, et al. Beneficial effects of psyllium on the prevention and treatment of obesity and metabolic syndrome: mechanisms and clinical evidence. 2022. Food & Function (Royal Society of Chemistry). https://pubs.rsc.org/en/content/articlehtml/2022/fo/d2fo00560c
↩Naeini EK, et al. Effect of creatine supplementation on kidney function: systematic review and meta-analysis. 2025. (Full text via PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC12590749/
↩Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. 2017. J Clin Sleep Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC5263083/
↩